Barriers to Accessing Specialized Myelofibrosis Care in Rural Areas | Challenges and Solutions
https://vimeo.com/1001812407 What are common myelofibrosis care barriers in rural areas? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses barriers that myelofibrosis patients in rural areas encounter and solutions for overcoming barriers…
Novel Therapies and Clinical Trials for Myelofibrosis | Updates and Innovations
https://vimeo.com/1001812578 What’s the latest in higher risk myelofibrosis novel therapies and clinical trials? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses JAK inhibitors and other research updates along with proactive patient…
How Does Risk Stratification Shape Myelofibrosis Treatment?
https://vimeo.com/1000239081 What is involved in determining low risk versus high risk myelofibrosis? Expert Dr. Michael Grunwald from Levine Cancer Institute discusses IPSS, DIPSS, MYSEC-PM, and MIPSS70 scoring systems, key patient factors they…
[ACT]IVATED Myelofibrosis Resource Guide en español
Descargar Guía Download Guide | Descargar Guía See More From [ACT]IVATED Myelofibrosis Share Your Feedback
[ACT]IVATED Myelofibrosis Resource Guide
Download Guide Download Guide | Descargar Guía See More From [ACT]IVATED Myelofibrosis Share Your Feedback
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask
https://vimeo.com/928809660 What questions should patients ask when considering a myelofibrosis clinical trial? Expert Dr. Gabriela Hobbs discusses how clinical trials may fit into a treatment plan and shares key questions…
What Are the Currently Approved Myelofibrosis Therapies?
https://vimeo.com/928808656 Expert Dr. Gabriela Hobbs shares an overview of available therapies and important considerations when choosing a myelofibrosis treatment plan. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the…
Myelofibrosis Clinical Trial Participation | How Does It Move Research Forward?
https://vimeo.com/928808368 How do clinical trials move myelofibrosis research forward? Expert Dr. Gabriela Hobbs discusses the purpose of clinical trials, factors that may impact participation, and how trials can benefit patients….
Which Emerging Myelofibrosis Therapies Are Showing Promise?
https://vimeo.com/928806986 What are the latest advances in myelofibrosis therapy? Expert Dr. Gabriela Hobbs discusses various inhibitor therapies, including BET inhibitors, that are currently being studied in clinical trials for patients…
Primary vs Secondary Myelofibrosis | What’s the Difference?
https://vimeo.com/928806744 How are primary myelofibrosis and secondary myelofibrosis defined? Expert Dr. Gabriela Hobbs explains the differences between the conditions and discusses a common scenario that secondary myelofibrosis patients often experience. …
Evolving Myelofibrosis Treatment Options: What You Should Know
https://vimeo.com/925945364 Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby…
Evolving Myelofibrosis Treatment Options: What You Should Know Resource Guide
Download Resource Guide Download Resource Guide See More from Evolve Myelofibrosis